Emerald Mutual Fund Advisers Trust T2 Biosystems, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$2.56 - $4.48 $398,261 - $696,958	-155,571 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$2.98 - $6.86 $330,511 - $760,842	-110,910 Reduced 41.62%	155,571 $468,000
Q3 2018 Oct 31, 2018	SELL	$5.36 - $7.83 $447,661 - $653,953	-83,519 Reduced 23.86%	266,481 $1.99 Million
Q2 2018 Jul 31, 2018	BUY	$5.97 - $9.58 $2.09 Million - $3.35 Million	350,000 New	350,000 $2.71 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.